Article
AMP-activated protein kinase promotes breast cancer stemness and drug resistance
23 Feb 2022
Abstract excerpt
Breast cancer stem cells (BCSCs) are a major cause of therapy resistance and tumour progression. Currently, their regulation is not entirely understood. Previous work from our laboratory demonstrated a context-specific pro-tumorigenic role for AMP-activated protein kinase (AMPK) under anchorage-deprivation and mammosphere formation, which are hallmarks of BCSCs. Therefore, we investigated the role of AMPK in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
